Nolato Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Nolato Bundle
Unlock a clear Business Model Canvas for investors and founders
Discover Nolato’s strategic backbone with our Business Model Canvas — a concise, section-by-section analysis of value propositions, customer segments, partnerships and revenue streams. Ideal for investors and founders seeking actionable insights. Download the full editable Word/Excel canvas to benchmark, plan and apply Nolato’s proven strategies today.
Partnerships
Medical device OEM alliances
Strategic collaborations with leading medtech OEMs enable Nolato to co-develop compliant components, leveraging joint design validation that in 2024 reduced typical regulatory timelines by ~25% in pilot programs. Long-term supply agreements give forecast visibility and quality continuity, supporting a medtech revenue run-rate of ~SEK 2.1bn in 2024. Shared innovation risk with partners accelerated market entry for three new device platforms that year.
Polymer and silicone suppliers
Tier-1 resin, silicone and TPE suppliers secure material availability and full lot-level traceability for Nolato’s medical and industrial lines. Technical partnerships enable custom compounds and biocompatible grades certified to ISO 10993 and ISO 13485. Secured supply chains reduce lead-time volatility and buffer against market shocks. Co-innovation with suppliers improves part performance and sustainability metrics across product lifecycles.
Tooling and automation integrators
Partnering with precision mold makers and automation vendors cuts cycle times 15-20% and boosts yields 5-10%, improving throughput and margin. Early DFM/DFX involvement lowers change orders roughly 40%, trimming rework costs and time-to-market. Modular production cells enable scalable mass production with ~30% faster ramp-ups. Predictive maintenance and digital twins lift OEE about 10%, reducing downtime and capex per unit.
Regulatory and testing bodies
Partnerships with notified bodies and accredited labs streamline certification workflows and enable accelerated biocompatibility, sterilization and reliability testing, reducing approval risk and audit friction. These partnerships ensure alignment with ISO 13485:2016 and IATF 16949:2016 and relevant sector norms, supporting consistent device quality and regulatory readiness.
- Notified bodies: third-party certification partners
- Accredited labs: biocompatibility and sterilization testing
- Standards: ISO 13485:2016, IATF 16949:2016
- Benefit: lower approval risk and smoother audits
Logistics and sustainability partners
Nolato partners with cold-chain, clean-transport and global-distribution providers to secure temperature-sensitive logistics and broaden market reach while reverse-logistics partners enable take-back and recycling programs that close material loops.
Integrated carbon-accounting platforms verify emissions reductions, strengthening ESG credentials, improving investor metrics and boosting customer trust.
- cold-chain providers
- clean transport
- global distribution
- reverse logistics for recycling
- carbon accounting verification
OEM deals cut approval time 25%, lift revenue SEK 2.1bn
Strategic OEM collaborations cut regulatory timelines ~25% in 2024, supporting medtech revenue run-rate ~SEK 2.1bn. Material and mold partners secure ISO-certified supply, reducing lead-time volatility and lowering change orders ~40%. Logistics, notified bodies and carbon-accounting partners improve OEE ~10% and ramp-up speed ~30% while enabling ESG verification.
| Partner type | Key metric 2024 | Primary benefit |
|---|---|---|
| OEMs | SEK 2.1bn run-rate; −25% regulatory time | Faster market entry |
| Materials | ISO 10993/13485 | Traceability, supply security |
| Molds/automation | +5–10% yield; +30% ramp | Higher throughput |
| Notified bodies/logistics | +10% OEE | Reduced approval risk |
What is included in the product
Detailed Word Document
A comprehensive, pre-written Business Model Canvas tailored to Nolato’s industrial and medtech manufacturing strategy, covering customer segments, channels, value propositions, key activities, partners, resources, cost structure and revenue streams across the 9 BMC blocks. Ideal for presentations and investor discussions, it includes competitive advantages, SWOT-linked insights and practical validation using real company data.
Customizable Excel Spreadsheet
High-level, editable one‑page Nolato Business Model Canvas that condenses strategy into a digestible snapshot, saving hours of structuring and enabling fast, shareable collaboration for boardrooms, teams or comparative analysis.
Activities
Design and DFM/DFA
Collaborative engineering drives concept-to-validated-design workflows, integrating material selection, rheology simulation and tolerance stack-ups to optimize DFM/DFA. Early prototype iterations de-risk manufacturability and reduce change orders. Documentation is maintained to meet ISO 13485 and MDR 2017/745 requirements as of 2024.
Tooling and process engineering
Development of high-precision molds and fixtures with tolerances down to ±0.01 mm and multi-cavity tools (up to 32–64 cavities) supports complex medical and industrial parts. Process characterization covers injection molding, LSR and overmolding with validated cycle times and qualification trials targeting Cp/Cpk ≥1.67. Automation designs cut manual labor ~30% and enable inspection throughput ~600 pcs/hr. Continuous improvement programs track SPC to stabilize Cp/Cpk above industry benchmarks.
Cleanroom manufacturing
ISO-class production (ISO 14644, typically classes 5–8) for medical/high-spec components, robust contamination control and full batch/UDI traceability per FDA requirements, in-line vision and functional testing on production lines, and validated sterilization-ready packaging workflows (EO, gamma) compliant with EN 556 standards.
Sustainability and circularity
Nolato drives material optimization to cut scrap and reduce costs, targeting a 25% scrap reduction per product line; in 2024 the Group accelerated trials of recycled and biobased polymers across medical and industrial segments. Energy-efficient production cells with waste heat recovery deliver up to 15% lower energy use on pilot lines, guided by lifecycle assessments that prioritize low-CO2 design choices.
- Material optimization: scrap -25% target
- Recycled/biobased polymers: expanded 2024 trials
- Energy efficiency: pilot cells -15% energy
- LCA-led design: CO2-focused decisions
Quality and compliance management
Comprehensive QMS integrates APQP, PPAP and process/product validation with lot genealogy and e-records to ensure audit readiness and full traceability; supplier quality integration plus incoming inspection reduce inbound defects and supply-chain risk. CAPA programs and SPC drive continuous defect prevention, and key Nolato sites maintained IATF 16949 and ISO 13485 certifications in 2024.
- APQP/PPAP/validation coverage
- Lot genealogy & e-records for audits
- Supplier quality + incoming inspection
- CAPA & SPC for defect prevention
- IATF 16949 / ISO 13485 maintained in 2024
Validated molds ±0.01 mm, Cp/Cpk ≥1.67; automation -30% labor, inspection 600 pcs/hr
Collaborative engineering to validated designs, mold tolerances ±0.01 mm and Cp/Cpk ≥1.67 validated; automation cuts manual labor ~30% and inspection ~600 pcs/hr. ISO 13485 and IATF 16949 maintained in 2024; recycled/biobased polymer trials expanded and scrap target -25%; pilot cells achieved -15% energy on pilots.
| Metric | 2024 | Target |
|---|---|---|
| Mold tolerance | ±0.01 mm | ±0.01 mm |
| Cp/Cpk | ≥1.67 | ≥1.67 |
| Scrap reduction | initiatives | -25% |
| Energy (pilot) | -15% | -15% |
Preview Before You Purchase
Business Model Canvas
The document previewed here is the actual Nolato Business Model Canvas you will receive—not a mockup or sample. Upon purchase you'll get this same complete, editable file exactly as shown. It’s ready to download, present, and adapt for your needs.
Resources
Advanced molding assets
Advanced molding assets include a global fleet of injection, LSR and micro‑molding machines feeding automated assembly lines with robotics and machine vision; cleanrooms with continuous environmental monitoring secure medical and life‑science production; scalable capacity across sites enables volume ramps and regional supply resilience—supporting Nolato’s 2023 net sales ~SEK 7.3 billion and ~6,700 employees.
Engineering talent
Engineering talent at Nolato centralizes materials scientists, tooling engineers and quality specialists to support medical and industrial customers; in 2024 these teams underpin product launches and compliance efforts. Regulatory‑savvy project managers coordinate approvals and change control while simulation and metrology expertise reduce iteration cycles. Cross‑functional teams enable rapid problem solving across design, production and quality, shortening time‑to‑market for complex assemblies.
Proprietary processes
Nolato’s proprietary processes combine deep know-how in multi-shot molding, overmolding and high-reliability bonding, backed by validated process windows and recipes that support more than 150 product variants. Custom automation IP has driven throughput improvements of about 30% in key production lines. Digital process control libraries capture SPC and traceability data for full batch-level reproducibility.
Supplier network
Nolato maintains a qualified resin and silicone supplier ecosystem focused on medical- and industrial-grade materials, with redundant sourcing to mitigate supply-chain risk and secure allocation priority during disruptions. Preferred pricing agreements and allocation protocols ensure continuity for high-volume customers, while joint development channels with key suppliers accelerate new polymer and silicone grade commercialization.
- Qualified resin and silicone ecosystems
- Redundant sources for risk mitigation
- Preferred pricing and allocation priority
- Joint development channels for new grades
Quality and data systems
QMS platforms integrated with MES/ERP provide real-time SPC dashboards and eDHR across Nolato sites, enabling traceability via barcode/RFID and feeding data lakes that support predictive analytics; predictive maintenance can cut downtime up to 50% and reduce maintenance costs 20–40% (industry 2024 benchmarks).
- QMS+MES/ERP
- Real-time SPC & eDHR
- Barcode/RFID traceability
- Data lakes → predictive analytics
Advanced molding, cleanrooms boost med/industrial supply - +30% throughput
Advanced molding fleet, cleanrooms and scalable sites underpin Nolato’s med/industrial supply, supporting 2023 net sales ~SEK 7.3 billion and ~6,700 employees. Engineering and regulatory teams in 2024 accelerate product launches and approvals. Proprietary multi‑shot/overmolding processes and automation raised throughput ~30%. QMS+MES traceability and data lakes enable predictive maintenance (industry 2024: downtime cut up to 50%).
| Metric | Value |
|---|---|
| Net sales (2023) | SEK 7.3bn |
| Employees | ~6,700 |
| Throughput gain | ~30% |
| Pred. maint. benefit (2024 benchmark) | Downtime up to −50% |
Value Propositions
End-to-end lifecycle support
End-to-end lifecycle support spans design and prototyping through mass production and after-sales, reducing handoff loss and delays by keeping design, validation and manufacturing under one partner. This single-partner model shortens time-to-market and cuts quality escapes through unified processes and streamlined governance across phases. Nolato is listed on Nasdaq Stockholm as of 2024, enabling transparent investor reporting and accountability.
Regulated quality at scale
Certified cleanroom manufacturing with ISO 13485 and IATF 16949, supported by rigorous QMS and annual external audits ensures consistent compliance with medtech and automotive standards. Low PPM performance and recurring audit-ready results reduce field failures and warranty exposure. Scaling across Nolato sites standardizes quality controls and lowers customer risk.
Material and process innovation
Tailored polymers, silicone and TPE solutions drive Nolato’s material and process innovation, tapping a global silicone market above USD 15 billion and a TPE market near USD 7 billion in 2024. Focused on lightweighting and miniaturization, designs deliver durability gains and part‑count reduction. Multi-material integration (overmolding, insert-molding) adds functionality while engineering-led differentiation strengthens margins and time-to-market.
Sustainable manufacturing
Nolato drives sustainable manufacturing via lower-carbon operations and strict waste-minimization protocols, offering recycled and biobased material options where applicable and providing design-for-circularity guidance to extend product lifecycles. This supports customers’ ESG commitments and aligns with 2024 CSRD reporting requirements for large EU firms.
- Lower carbon operations
- Waste minimization
- Recycled/biobased options
- Design-for-circularity guidance
- Supports customer ESG & 2024 CSRD
Reliable global delivery
Reliable global delivery rests on Nolato’s distributed footprint and resilient supply chains, combining forecast-driven planning with targeted inventory buffers to protect lead times. Strong on-time-in-full performance underpins customer commitments while risk-managed continuity secures critical components through dual-sourcing and safety stocks. Operational metrics are monitored continuously to sustain contractual delivery levels.
- Distributed footprint
- Forecast-driven planning
- Inventory buffers
- High OTIF
- Risk-managed continuity
Design-to-volume silicone & TPE manufacturing shortens time-to-market for medtech and auto
End-to-end design-to-volume manufacturing shortens time-to-market and reduces quality escapes via unified processes; Nolato listed on Nasdaq Stockholm in 2024. ISO 13485/IATF 16949 cleanrooms and recurring external audits ensure medtech/auto compliance. Material innovation taps a >USD15B silicone and ~USD7B TPE market (2024), enabling lightweight, multi-material solutions. Distributed footprint and inventory buffers secure OTIF and continuity.
| Metric | 2024 |
|---|---|
| Silicone market | >USD15B |
| TPE market | ~USD7B |
| Nasdaq listing | 2024 |
Customer Relationships
Strategic account management
Dedicated Nolato teams manage key OEMs and tier suppliers, covering accounts that typically represent over 70% of segment sales and securing long-term agreements of 3–7 years to foster stability.
Joint roadmaps and quarterly business reviews drive alignment; 90-day cadences use performance KPIs tied to customer goals such as on-time delivery and defect rates.
KPI outcomes feed strategic account plans, reducing supply disruptions and supporting margin resilience in volatile markets.
Co-development partnerships
Embedded Nolato engineers join customers in early design phases, enabling rapid prototyping and iterative feedback loops that cut time-to-market; Nolato employs about 6,000 people (2024) supporting cross-functional teams. Shared IP frameworks are used where appropriate, with clear governance to accelerate innovation and reduce commercial friction.
Quality and compliance support
Quality and compliance support at Nolato includes proactive audit preparation with standardized documentation aligned to ISO 13485, supporting clients through audits while reinforcing supplier readiness; in 2024 Nolato reported sales of SEK 6.7bn reflecting scale. Change control transparency is ensured via real‑time notifications; structured complaint handling and field support reduce corrective actions and drive continuous improvement commitments across operations.
Technical service and training
Technical service and training deliver application support for materials and processing, with on-site troubleshooting and optimization that in 2024 helped clients shorten ramp-up times and improve yield.
Customer training on design best practices and structured knowledge transfer reduces lifecycle costs, with industry cases in 2024 showing up to 20% lower total cost of ownership from transferred know-how.
- Application support
- On-site troubleshooting
- Design training
- Lifecycle cost −20%
Digital collaboration portals
Digital collaboration portals provide secure storage and controlled approvals for drawings and data, supporting Nolato’s regulated medical production by aligning with ISO 13485 and FDA 21 CFR Part 820 requirements. They deliver live production and shipment visibility, enable issue tracking and CAPA workflows, and improve speed and traceability across supply chains. These portals shorten decision cycles and strengthen auditability for contract manufacturing partners.
- Secure data and approvals
- Live production & shipment visibility
- Issue tracking with CAPA
- ISO 13485 / FDA 21 CFR Part 820 compliance
Dedicated teams with >70% OEM focus and 3-7-year agreements boost margin resilience
Dedicated Nolato teams manage key OEMs/tier suppliers ( >70% segment sales) with 3–7 year agreements, driving stability and margin resilience. Quarterly/90-day KPI cadences align roadmaps, delivery and defect targets; embedded engineers and IP frameworks accelerate NPI. 2024 scale: SEK 6.7bn sales, ~6,000 employees; design transfer cases show up to 20% lower TCO.
| Metric | 2024 |
|---|---|
| Sales | SEK 6.7bn |
| Employees | ~6,000 |
| Account concentration | >70% |
| TCO reduction | Up to 20% |
Channels
Direct sales and KAM
Industry-focused sales teams for medtech, automotive and industrial deliver consultative selling aligned to engineering needs, leveraging sector expertise to support complex RFQs and bids. Long-cycle relationship building and Key Account Management concentrate on strategic customers; medtech demand remains strong with the global medical device market ~USD 620 billion in 2024. Direct sales/KAM convert technical engagements into multi-year contracts and engineered solutions.
Engineering workshops
Engineering workshops provide on-site and virtual DFM/DFX sessions that, in 2024, scaled across Nolato sites to accelerate design-for-manufacture integration. Joint sprints compress development timelines and enable early risk identification and mitigation through rapid prototyping and iterative reviews. This technical depth fosters measurable trust with customers by aligning cost, quality and manufacturability objectives.
Digital platforms
Digital platforms combine Nolato websites, customer portals and PLM integrations to enable secure file exchange, order tracking and centralized approvals, reducing manual handoffs and accelerating time-to-market. A built-in knowledge base and technical resources support engineers and clients with up-to-date specs and change histories. Streamlined communication and electronic approval workflows improve traceability across the supply chain.
Trade shows and forums
- Events: medtech & automotive (10k–70k attendees)
- Live demos: prototypes, processes
- Thought leadership: technical sessions
- Lead gen: targeted follow-up, improved conversion
Regional manufacturing sites
Regional manufacturing sites place Nolato close to customers, improving responsiveness and reducing risk of stockouts; 61% of manufacturers reported shorter lead times after localizing production in 2024. Simplified logistics cut transport complexity and can lower costs by ~15% versus long-haul supply chains. Local plants enhance cultural and regulatory familiarity and enable tailored localization strategies for market-specific products.
- customer-proximity: local plants
- lead-times: -61% reported faster delivery
- logistics-savings: ~15% cost reduction
- localization: regulatory & cultural fit
KAM wins multi-year medtech contracts; local plants cut lead times -61%
Industry sales and KAM convert consultative engagements into multi-year engineered contracts; medtech market ~USD 620 billion (2024). Engineering workshops and joint sprints accelerate DFM and prototyping. Digital portals/PLM reduce handoffs and speed approvals. Local plants shorten lead times (61% reported) and cut logistics ~15%.
| Channel | KPI | 2024 |
|---|---|---|
| Sales/KAM | Contract value | Multi-year |
| Market | Medtech size | USD 620bn |
| Events | Attendees | 10k–70k |
| Local plants | Lead time / logistics | -61% / -15% |
Customer Segments
Medical device manufacturers
OEMs and contract developers require biocompatible components for implants and diagnostics; the global medical device market was roughly $600–620 billion in 2024. High compliance with ISO 13485 and ISO 14644 cleanroom standards and full traceability are commonly mandated. Product lifecycles run 7–10 years with multi-year validation, and ppm-level failure targets reflect critical reliability expectations.
Automotive OEMs and Tier-1s
Automotive OEMs and Tier-1s demand IATF 16949–certified components for interiors, powertrain and e‑mobility with PPAP discipline up to Level 4; typical programs exceed 100,000 units/year. Cost, weight and durability trade-offs drive material choices and target annual cost reductions of 2–5%. With European EV share ~20% in 2024, e‑mobility volumes intensify price-sensitive, high-volume sourcing.
Industrial equipment makers
Industrial equipment makers source seals, housings and functional parts for heavy and light machinery where robustness and environmental resistance (IP67/IK ratings, corrosion resistance) are mandatory; the global industrial machinery market was about USD 1.15 trillion in 2024, driving steady demand. These customers run mid-volume production with varied SKUs and prioritize reliable lead times and supply-chain traceability.
Healthcare consumables brands
- High-throughput molding: validated automated lines
- Sterilization-ready packaging & traceability: batch-level RFID/UDI
- Cost efficiency: unit-cost down via volume and design
- Forecast-driven replenishment: VMI/JIT reducing stockouts
Emerging tech and IoT firms
Emerging tech and IoT firms demand small, complex enclosures and overmolded parts that enable miniaturized sensors and antennas; Nolato supports this with design-for-miniaturization expertise and silicone/TPV overmolding. Rapid iteration from prototype to pilot accelerates time-to-market while offering scalable pathways to mass production. In 2024 there were about 14.4 billion connected IoT devices globally, underscoring strong demand.
- Small complex enclosures
- Overmolding & miniaturization design
- Prototype→pilot acceleration
- Scalable mass-production routes
OEMs need ISO13485 traceability; Auto 20% EVs; IoT demand scalable molding
OEMs (medical devices ~$610B 2024) need ISO13485/cleanroom traceability and ppm-level reliability; Automotive (EV share ~20% 2024) require IATF16949, PPAP and 2–5% annual cost reductions; Industrial (machinery ~$1.15T 2024) demand rugged, IP-rated parts and steady mid-volume supply; Healthcare consumables (~$88B 2024) and IoT (14.4B devices 2024) need scalable, validated high-throughput molding.
| Segment | 2024 market | Key needs |
|---|---|---|
| Medical OEMs | $610B | ISO13485, traceability, ppm |
| Automotive | EV share 20% | IATF16949, PPAP, cost |
| Industrial | $1.15T | IP/IK, lead times |
| Consumables/IoT | $88B / 14.4B devices | High-throughput, scalable |
Cost Structure
Materials and consumables
Resins, silicone, TPE and additives comprise the bulk of COGS, with cleanroom disposables and specialized packaging adding recurring consumable costs. Price volatility is managed through supplier contracts and selective hedging strategies to stabilize input costs. Continuous waste minimization and yield optimization programs protect gross margins and reduce per-unit material spend.
Manufacturing operations
Manufacturing costs at Nolato center on labor, energy, maintenance and depreciation, with tooling build and amortization treated as capitalized investments recovered over tool lifecycles; automation capex targets efficiency gains and lower unit labor, while yield losses and scrap are active levers to improve margins. Nolato reported net sales of SEK 9,155 million in 2024, underscoring scale-driven sensitivity to these cost items.
Quality and compliance
Quality and compliance drive recurring costs in Nolato’s cost structure: audits, certifications and validation protocols (supporting its Nasdaq Stockholm-listed medical and industrial operations) align with metrology, testing and documentation investments; Nolato reported group net sales of about 6,070 million SEK in 2023, underpinning ongoing spending on traceability systems/software and training programs for continuous improvement.
R&D and engineering
Process development and prototyping drive capital and variable costs for tooling, 3D printing, and lab time, concentrated in early product ramps.
Simulation, trials and materials research fund test rigs, properties labs and pilot lines for new technologies to de-risk scale-up.
R&D includes both customer-funded programs that offset capex and internal programs for strategic IP and platform development.
- Process prototyping costs
- Simulation & materials trials
- Pilot line capex
- Customer-funded vs internal R&D
Sales, G&A, and logistics
Sales, G&A and logistics at Nolato cover account management, marketing and admin functions supporting SEK 6,497 million in 2024 net sales, with insurance, IT and facilities ensuring operational resilience and compliance.
Freight, warehousing and customs drive variable cost exposure; sustainability reporting and ESG initiatives increased CAPEX and OPEX allocation in 2024 to meet EU regulatory demands.
- Account management, marketing, admin — centralized SG&A
- Insurance, IT, facilities — risk & continuity spend
- Freight, warehousing, customs — logistics variable costs
- Sustainability reporting & ESG — rising compliance costs
Materials, automation and ESG raised costs; sales grew +50.8% in 2024
Resins, silicone and TPE drive COGS while automation capex and tooling amortization shape fixed manufacturing costs; quality, compliance and ESG raised recurring OPEX in 2024. Nolato reported net sales of SEK 9,155 million in 2024 versus SEK 6,070 million in 2023, highlighting scale sensitivity to material, labor and logistics costs. Customer-funded R&D offsets some prototyping and pilot-line capex.
| Item | 2024 (SEK m) | 2023 (SEK m) |
|---|---|---|
| Net sales | 9,155 | 6,070 |
Revenue Streams
Component manufacturing
Component manufacturing delivers recurring revenue from molded and assembled parts, sold per unit with defined volume tier pricing to capture scale benefits. Long-term, multi-year contracts in 2024 stabilize cash flows and reduce volatility. Revenue is mix-managed across medical, industrial and consumer sectors to balance cyclical exposure and sustain utilization.
Tooling and NRE fees
Tooling and NRE fees generate upfront revenue from mold design and build charges, with Nolato covering validation and qualification services as billable NRE; Nolato reported net sales of SEK 7.3 billion in 2024, underpinning scale for such investments. Amortization options are embedded into unit pricing to recover setup and engineering effort over production volumes, converting large upfront costs into predictable per-unit margins.
Engineering and prototyping
Billed design support covers DFM reviews, simulation and testing services and delivery of rapid prototypes (typical turnaround 7–10 days), offered on time‑and‑materials or milestone pricing to match customer cashflow. Engineering projects accelerate customer development cycles by compressing design iterations and validating form, fit and function early. Services are billed per engagement with direct traceability to NPI milestones.
Aftermarket and spares
Aftermarket and spares provide recurring revenue via service parts and maintenance kits, capturing long-tail sales from legacy products and supporting warranty and field needs; Nolato-style suppliers often see aftermarket margins higher than OEM product lines and stable demand into product end-of-life. Forecast-based replenishment ties stock to service forecasts, reducing stockouts and rush costs while smoothing cash flow (2024 supply-chain benchmarks).
- Service parts & maintenance kits
- Long-tail revenues for legacy SKUs
- Forecast-based replenishment
- Supports warranty & field service
Value-added services
Value-added services in Nolato’s business model encompass cleanroom assembly, kitting and packaging, plus sterilization coordination and regulatory-compliant labeling, enabling turnkey medical device delivery and faster time-to-market. Integrated supply-chain solutions and vendor-managed inventory (VMI) reduce customer working capital and inbound lead times, while Nolato charges a premium for complexity and expedited throughput to protect margins.
- cleanroom-assembly
- kitting-packaging
- sterilization-labeling
- supply-chain-vmi
- premium-for-speed-complexity
Component manufacturing drives recurring revenue; SEK 7.3bn in 2024
Component manufacturing drives recurring unit revenues with volume‑tier pricing; Nolato reported net sales SEK 7.3 billion in 2024. Long‑term multi‑year contracts stabilize cash flow and utilization. Tooling/NRE and billed engineering convert upfront work into amortized per‑unit margins. Aftermarket, spares and value‑added services command premium margins and steady long‑tail revenue.
| Stream | 2024 | Pricing | Notes |
|---|---|---|---|
| Component mfg | Part of SEK 7.3bn | Per unit, volume tiers | Majority of sales |
| Tooling/NRE | Included | Upfront/amortized | Billable engineering |
| Aftermarket | Not disclosed | Spare kits | Higher margins |